Изследване за носителство на генетични заболявания
Помага на родителите да открият генетични рискове навреме и да предотвратят вродени дефекти при поколението.
Първата стъпка към отговорно и спокойно родителство – едно от най-важните неща, които може да направиш докато се подготвяш да станеш родител, е да узнаеш дали си носител на определени генетични заболявания.
Изследването за носителство проверява за потенциални заболявания, които родителите могат да предадат на децата си. Тези генетични заболявания може да предизвикат сериозни здравословни проблеми, да повлияят на умственото развитие или да доведат до по-кратка продължителност на живота.
Изследването може да бъде извършено преди зачатие или по всяко време от бременността.
За да ти помогнем да избереш най-подходящия за теб вариант на изследване, свържи се с нас за консултация и записване на час за изследване!
Какво означава да си носител?
Всеки човек наследява два комплекта хромозоми от родителите си – 23 от майката и 23 от бащата. Много генетични заболявания са рецесивни, което означава, че заболяването се проявява само при унаследяване на два изменени (мутирали) гена, по един от всеки родител. Ако човек има мутация в един от двата комплекта хромозоми, то той е носител на генетичното заболяване.
Един носител има 50% вероятност да предаде същата мутация на детето си. Ако и двамата родители са носители, детето ще има 25% вероятност да унаследи и двете копия на мутацията и в последствие да развие заболяването. Рискът за унаследяване на някои генетични заболявания е по-голям в определени етнически групи и при хора със случаи на генетични заболявания в рода.

Как генетично изследване за носителство на генетични заболявания може да ми помогне?
Това е обширно генетично изследване за определяне на носителски статус за редица генетични заболявания. То дава надеждна и навременна информация за потенциалните рискове за здравето на бъдещите ти деца.
Скринингът за носителство, извършен преди бременността, ще ти даде възможност за по-широк набор от възможности, съответстващи на твоите ценности, и ще ти предостави повече време за вземане на информирано решение за да предотвратиш вродени дефекти при тях.
Изследва за носителство на над 1200 рецесивни генетични заболявания.
Може да се извърши както преди зачатие, така и по време на бременността.
Подходящо е за бъдещи родители, които искат да разберат дали децата им биха имали риск да унаследят определени генетични заболявания.
Подходящо е и за хора от определени етнически групи или при случаи на генетични заболявания в рода и семейството.
Изследването и на двамата бъдещи родители едновременно е силно препоръчително, за да се получи по-точна картина на възможните рискове за децата.
Изследвания, които предлагаме
VISTA™ Carrier Screening
Изследването се извършва от лаборатория BGI, водеща генетична лаборатория с клонове в Европа, Китай, САЩ, и други локации.
Vista Carrier Screening (1200+) – тест с покритие на 1200 гена
Включва изследване и на:
- Синдром на чупливата Х-хромозома
- Хемофилия А
- Цена на изследване за 1 човек: 2000 лв / 1 022,58 €
- Цена на изследване за двойка: 3598,73 лв / 1840,00 €
Включена консултация с лекар генетик
Към услугата е включена консултация със специалист по медицинска генетика след получаване на резултатите, за да обсъдите в детайл какво означава той и какви стъпки е добре да предприемеш след него, за да предотвратиш вродени дефекти при бъдещите си деца.
Какво включва изследването?
| NO. | Заболяване | Ген |
| 1 | Laron dwarfism | GHR |
| 2 | Congenital Adrenal Hyperplasia due to 11-beta-Hydroxylase-Deficiency | CYP11B1 |
| 3 | Congenital Adrenal Hyperplasia due to 17-alpha Hydroxylase Deficiency | CYP17A1 |
| 4 | 2,4-Dienoyl-CoA Reductase Deficiency | NADK2 |
| 5 | 2-Methylbutyryl Glycinuria | ACADSB |
| 6 | 3MC Syndrome 1 | MASP1 |
| 7 | 3MC Syndrome 2 | COLEC11 |
| 8 | 3-M Syndrome 2 | OBSL1 |
| 9 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency | HSD3B2 |
| 10 | 3-Methylglutaconic Aciduria type 1 | AUH |
| 11 | 3-Methylglutaconic Aciduria type 3 | OPA3 |
| 12 | 3-Methylglutaconic Aciduria type 5 | DNAJC19 |
| 13 | 3-Methylglutaconic Aciduria type 8 | HTRA2 |
| 14 | 3-Methylglutaconic Aciduria With Cataracts, Neurologic Involvement,And Neutropenia | CLPB |
| 15 | 3-Methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | SERAC1 |
| 16 | 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency | HMGCS2 |
| 17 | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency | HMGCL |
| 18 | 3-Hydroxyisobutyryl-Coa Hydrolase Deficiency | HIBCH |
| 19 | Pyridoxal 5′-Phosphate-dependent Epilepsy | PNPO |
| 20 | GM2-gangliosidosis, AB variant | GM2A |
| 21 | Adams-Oliver Syndrome 2 | DOCK6 |
| 22 | Adams-Oliver Syndrome 4 | EOGT |
| 23 | Aicardi-Goutieres Syndrome 1 | TREX1 |
| 24 | Aicardi-Goutieres Syndrome 2 | RNASEH2B |
| 25 | Aicardi-Goutieres Syndrome 3 | RNASEH2C |
| 26 | Aicardi-Goutieres Syndrome 4 | RNASEH2A |
| 27 | Aicardi-Goutieres Syndrome 5 | SAMHD1 |
| 28 | Aicardi-Goutieres Syndrome 6 | ADAR |
| 29 | Al Kaissi syndrome | CDK10 |
| 30 | Alazami Syndrome | LARP7 |
| 31 | Alkuraya-Kucinskas Syndrome | BLTP1 |
| 32 | Allan-Herndon-Dudley syndrome | SLC16A2 |
| 33 | Alstrom Syndrome | ALMS1 |
| 34 | Anauxetic dysplasia 2 | POP1 |
| 35 | Antley-Bixler Syndrome With Genital Anomalies And Disordered Steroidogenesis | POR |
| 36 | Arts Syndrome | PRPS1 |
| 37 | Athabaskan Brain Stem Dysgenesis Syndrome | HOXA1 |
| 38 | Baller-Gerold Syndrome | RECQL4 |
| 39 | Bardet-Biedl syndrome 10 | BBS10 |
| 40 | Bardet-Biedl syndrome 12 | BBS12 |
| 41 | Bardet-Biedl syndrome 16 | SDCCAG8 |
| 42 | Bardet-Biedl syndrome 17 | LZTFL1 |
| 43 | Bardet-Biedl syndrome 1 | BBS1 |
| 44 | Bardet-Biedl syndrome 2 | BBS2 |
| 45 | Bardet-Biedl syndrome 3 | ARL6 |
| 46 | Bardet-Biedl syndrome 4 | BBS4 |
| 47 | Bardet-Biedl syndrome 5 | BBS5 |
| 48 | Bardet-Biedl syndrome 7 | BBS7 |
| 49 | Bardet-Biedl syndrome 8 | TTC8 |
| 50 | Bardet-Biedl syndrome 9 | BBS9 |
| 51 | Barth syndrome | TAFAZZIN |
| 52 | Bartter Syndrome 1 | SLC12A1 |
| 53 | Bartter Syndrome 2 | KCNJ1 |
| 54 | Basel-Vanagait-Smirin-Yosef syndrome | MED25 |
| 55 | BEHR syndrome | OPA1 |
| 56 | BH4-Deficient Hyperphenylalaninemia C | QDPR |
| 57 | Chondrodysplasia, Blomstrand Type | PTH1R |
| 58 | Bloom syndrome | BLM |
| 59 | Borjeson-Forssman-Lehmann syndrome | PHF6 |
| 60 | Boucher-Neuhauser syndrome | PNPLA6 |
| 61 | Brachyolmia Type 4 | PAPSS2 |
| 62 | Brown-Vialetto-Van Laere syndrome 1 | SLC52A3 |
| 63 | Brown-Vialetto-Van Laere syndrome 2 | SLC52A2 |
| 64 | Bruck Syndrome 1 | FKBP10 |
| 65 | Bruck Syndrome 2 | PLOD2 |
| 66 | Brunner syndrome | MAOA |
| 67 | Burn-Mckeown Syndrome | TXNL4A |
| 68 | Canavan Disease | ASPA |
| 69 | Carey-Fineman-Ziter syndrome | MYMK |
| 70 | Carpenter syndrome 1 | RAB23 |
| 71 | Carpenter Syndrome 2 | MEGF8 |
| 72 | Cerebellar Ataxia, Cayman Type | ATCAY |
| 73 | Cenani-Lenz Syndactyly Syndrome | LRP4 |
| 74 | Chanarin-Dorfman syndrome | ABHD5 |
| 75 | Charcot-Marie-Tooth disease, Axonal, Type 2A2B | MFN2 |
| 76 | Charcot-Marie-Tooth disease type 3 | PRX |
| 77 | Charcot-Marie-Tooth disease type 4B1 | MTMR2 |
| 78 | Charcot-Marie-Tooth disease type 4C | SH3TC2 |
| 79 | Charcot-Marie-Tooth disease type 4D | NDRG1 |
| 80 | Chediak-Higashi Syndrome | LYST |
| 81 | X-Linked Syndromic Mental Retardation, Christianson type | SLC9A6 |
| 82 | Chudley-McCullough Syndrome | GPSM2 |
| 83 | X-Linked Syndromic Mental Retardation, Claes-Jensen type | KDM5C |
| 84 | COACH syndrome | TMEM67, CC2D2A |
| 85 | Cockayne Syndrome A | ERCC8 |
| 86 | Cockayne Syndrome B | ERCC6 |
| 87 | CODAS Syndrome | LONP1 |
| 88 | Coffin-Lowry Syndrome | RPS6KA3 |
| 89 | Cohen Syndrome | VPS13B |
| 90 | Crigler-Najjar syndrome type 1 | UGT1A1 |
| 91 | D,L-2-hydroxyglutaric aciduria | SLC25A1 |
| 92 | D-2-hydroxyglutaric aciduria 1 | D2HGDH |
| 93 | DCLRE1C-Related Severe Combined Immunodeficiency | DCLRE1C |
| 94 | Desbuquois Dysplasia 1 | CANT1 |
| 95 | Desbuquois Dysplasia 2 | XYLT1 |
| 96 | Donnai-Barrow syndrome | LRP2 |
| 97 | Dyggve-Melchior-Clausen Disease | DYM |
| 98 | D-Glyceric Aciduria | GLYCTK |
| 99 | Ehlers-Danlos Syndrome type VI | PLOD1 |
| 100 | Ehlers-Danlos syndrome type VIIC | ADAMTS2 |
| 101 | Ehlers-Danlos Syndrome with Progressive Kyphoscoliosis, Myopathy, and Hearing Loss | FKBP14 |
| 102 | Ellis-van Creveld Syndrome | EVC,EVC2 |
| 103 | Elsahy-Waters syndrome | CDH11 |
| 104 | MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT | CHRNG |
| 105 | Fabry Disease | GLA |
| 106 | Fanconi-Bickel Syndrome | SLC2A2 |
| 107 | Farber Lipogranulomatosis | ASAH1 |
| 108 | FG Syndrome Type 2 | FLNA |
| 109 | FG Syndrome Type 4 | CASK |
| 110 | Filippi Syndrome | CKAP2L |
| 111 | Frank-ter Haar Syndrome | SH3PXD2B |
| 112 | Fraser Syndrome 1 | FRAS1 |
| 113 | Fraser syndrome 2 | FREM2 |
| 114 | Fraser syndrome 3 | GRIP1 |
| 115 | X-linked Mental retardation, FRAXE type | AFF2 |
| 116 | GABA-Transaminase Deficiency | ABAT |
| 117 | Galloway-Mowat Syndrome 1 | WDR73 |
| 118 | Galloway-Mowat syndrome 3 | OSGEP |
| 119 | Geleophysic dysplasia 1 | ADAMTSL2 |
| 120 | Spondyloepimetaphyseal Dysplasia, Genevieve Type | NANS |
| 121 | Goldberg-Shprintzen syndrome | KIFBP |
| 122 | Gracile Syndrome | BCS1L |
| 123 | Greenberg dysplasia | LBR |
| 124 | Griscelli Syndrome 2 | RAB27A |
| 125 | Dopa-Responsive Dystonia | GCH1 |
| 126 | Hennekam Lymphangiectasia-Lymphedema Syndrome 1 | CCBE1 |
| 127 | Hennekam Lymphangiectasia-Lymphedema Syndrome 2 | FAT4 |
| 128 | Hermansky-Pudlak Syndrome 1 | HPS1 |
| 129 | Hermansky-Pudlak Syndrome 3 | HPS3 |
| 130 | Hermansky-Pudlak Syndrome 4 | HPS4 |
| 131 | Hermansky-Pudlak Syndrome 5 | HPS5 |
| 132 | Hermansky-Pudlak Syndrome 6 | HPS6 |
| 133 | Hurler-Scheie Syndrome | IDUA |
| 134 | Hurler Syndrome | IDUA |
| 135 | X-linked immunodysregulation, polyendocrinopathy, and enteropathy | FOXP3 |
| 136 | Jalili Syndrome | CNNM4 |
| 137 | Jervell and Lange-Nielsen syndrome 1 | KCNQ1 |
| 138 | Jervell and Lange-Nielsen syndrome 2 | KCNE1 |
| 139 | Johanson-Blizzard Syndrome | UBR1 |
| 140 | Joubert Syndrome 10 | OFD1 |
| 141 | Joubert Syndrome 14 | TMEM237 |
| 142 | Joubert Syndrome 15 | CEP41 |
| 143 | Joubert Syndrome 16 | TMEM138 |
| 144 | Joubert Syndrome 17 | CPLANE1 |
| 145 | Joubert Syndrome 18 | TCTN3 |
| 146 | Joubert Syndrome 1 | INPP5E |
| 147 | Joubert Syndrome 20 | TMEM231 |
| 148 | Joubert Syndrome 21 | CSPP1 |
| 149 | Joubert Syndrome 24 | TCTN2 |
| 150 | Joubert Syndrome 2 | TMEM216 |
| 151 | Joubert Syndrome 3 | AHI1 |
| 152 | Joubert Syndrome 4 | NPHP1 |
| 153 | Joubert Syndrome 5 | CEP290 |
| 154 | Joubert Syndrome 6 | TMEM67 |
| 155 | Joubert Syndrome 8 | ARL13B |
| 156 | Joubert Syndrome 9 | CC2D2A |
| 157 | Kenny-Caffey Syndrome Type 1 | TBCE |
| 158 | Keutel Syndrome | MGP |
| 159 | Kindler Syndrome | FERMT1 |
| 160 | Knobloch Syndrome Type I | COL18A1 |
| 161 | Kohlschutter-Tonz Syndrome | ROGDI |
| 162 | Krabbe Disease | GALC |
| 163 | L-2-hydroxyglutaric aciduria | L2HGDH |
| 164 | Lafora Disease | EPM2A |
| 165 | LAMA3-Related Junctional Epidermolysis Bullosa | LAMA3 |
| 166 | LAMB3-Related Junctional Epidermolysis Bullosa | LAMB3 |
| 167 | LAMC2-Related Junctional Epidermolysis Bullosa | LAMC2 |
| 168 | Leber Congenital Amaurosis 12 | RD3 |
| 169 | Leber Congenital Amaurosis 13 | RDH12 |
| 170 | Leber congenital amaurosis 14 | LRAT |
| 171 | Leber Congenital Amaurosis 1 | GUCY2D |
| 172 | Leber Congenital Amaurosis 2 | RPE65 |
| 173 | Leber Congenital Amaurosis 3 | SPATA7 |
| 174 | Leber Congenital Amaurosis 5 | LCA5 |
| 175 | Leber Congenital Amaurosis 8 | CRB1 |
| 176 | Leber Congenital Amaurosis 9 | NMNAT1 |
| 177 | Lesch-Nyhan Syndrome | HPRT1 |
| 178 | LIG4 syndrome | LIG4 |
| 179 | Lowe Syndrome | OCRL |
| 180 | Lujan-Fryns syndrome | MED12 |
| 181 | Majeed Syndrome | LPIN2 |
| 182 | Marinesco-Sjogren Syndrome | SIL1 |
| 183 | MASA syndrome | L1CAM |
| 184 | McKusick-Kaufman Syndrome | MKKS |
| 185 | Meckel syndrome 1 | MKS1 |
| 186 | Meckel Syndrome 2 | TMEM216 |
| 187 | Meckel Syndrome 3 | TMEM67 |
| 188 | Meckel Syndrome 4 | CEP290 |
| 189 | Meckel syndrome 5 | RPGRIP1L |
| 190 | Neonatal Severe Encephalopathy Due To MECP2 Mutations | MECP2 |
| 191 | Meester-Loeys syndrome | BGN |
| 192 | Congenital Muscular Dystrophy, Megaconial type | CHKB |
| 193 | MEHMO syndrome | EIF2S3 |
| 194 | Meier-Gorlin Syndrome 1 | ORC1 |
| 195 | Meier-Gorlin Syndrome 3 | ORC6 |
| 196 | Meier-Gorlin Syndrome 4 | CDT1 |
| 197 | Meier-Gorlin syndrome 7 | CDC45 |
| 198 | Menkes Disease | ATP7A |
| 199 | Merosin-deficient congenital muscular dystrophy type 1A | LAMA2 |
| 200 | Miller syndrome | DHODH |
| 201 | Mitchell-Riley syndrome | RFX6 |
| 202 | Mohr-Tranebjaerg syndrome | TIMM8A |
| 203 | Recurrent Pyogenic Bacterial Infections due to MYD88 Deficiency | MYD88 |
| 204 | X-Linked Syndromic Mental Retardation, Nascimento-type | UBE2A |
| 205 | Naxos Disease | JUP |
| 206 | Netherton syndrome | SPINK5 |
| 207 | Neu-Laxova Syndrome 1 | PHGDH |
| 208 | Neu-Laxova Syndrome 2 | PSAT1 |
| 209 | Niemann-Pick Disease Type A | SMPD1 |
| 210 | Niemann-Pick Disease Type B | SMPD1 |
| 211 | Niemann-Pick Disease Type C1 | NPC1 |
| 212 | Niemann-Pick Disease Type C2 | NPC2 |
| 213 | Norrie Disease | NDP |
| 214 | N-acetylglutamate synthase deficiency | NAGS |
| 215 | Ogden Syndrome | NAA10 |
| 216 | Spondyloepiphyseal Dysplasia, Omani type | CHST3 |
| 217 | Omenn syndrome | RAG1, RAG2 |
| 218 | Opitz Gbbb Syndrome, Type I | MID1 |
| 219 | Opsismodysplasia | INPPL1 |
| 220 | PEHO syndrome | ZNHIT3 |
| 221 | Perlman Syndrome | DIS3L2 |
| 222 | Perrault Syndrome 3 | CLPP |
| 223 | Perrault Syndrome 4 | LARS2 |
| 224 | Peters Plus Syndrome | B3GLCT |
| 225 | Pierson Syndrome | LAMB2 |
| 226 | Pitt-Hopkins like syndrome 1 | CNTNAP2 |
| 227 | Poretti-Boltshauser syndrome | LAMA1 |
| 228 | Raine Syndrome | FAM20C |
| 229 | X-Linked Syndromic Mental Retardation, Raymond type | ZDHHC9 |
| 230 | Renpenning syndrome | PQBP1 |
| 231 | Sandhoff Disease | HEXB |
| 232 | Metachromatic leukodystrophy due to Saposin B deficiency | PSAP |
| 233 | Schimke Immunoosseous Dysplasia | SMARCAL1 |
| 234 | Schneckenbecken Dysplasia | SLC35D1 |
| 235 | Schwartz-Jampel Syndrome, Type 1 | HSPG2 |
| 236 | Schwartz-Jampel Syndrome, Type 2 | LIFR |
| 237 | SC Phocomelia Syndrome | ESCO2 |
| 238 | Seckel Syndrome Type 1 | ATR |
| 239 | Seckel Syndrome Type 2 | RBBP8 |
| 240 | Seckel Syndrome Type 5 | CEP152 |
| 241 | Tyrosine Hydroxylase Deficiency | TH |
| 242 | Sengers syndrome | AGK |
| 243 | Senior-Loken Syndrome 4 | NPHP4 |
| 244 | Senior-Loken syndrome 5 | IQCB1 |
| 245 | Senior-Loken Syndrome 8 | WDR19 |
| 246 | Shwachman-Diamond Syndrome | SBDS |
| 247 | X-linked Mental retardation syndrome, Siderius type | PHF8 |
| 248 | Simpson-Golabi-Behmel Syndrome Type 1 | GPC3 |
| 249 | Sjögren-Larsson syndrome | ALDH3A2 |
| 250 | Smith-Lemli-Opitz syndrome | DHCR7 |
| 251 | Smith-McCort Dysplasia 2 | RAB33B |
| 252 | Snyder-Robinson mental retardation syndrome | SMS |
| 253 | Steel Syndrome | COL27A1 |
| 254 | TARP Syndrome | RBM10 |
| 255 | Tay-Sachs Disease | HEXA |
| 256 | Temtamy Preaxial Brachydactyly Syndrome | CHSY1 |
| 257 | Temtamy Syndrome | C12orf57 |
| 258 | Tenascin-X deficiency type Ehlers-Danlos syndrome | TNXB |
| 259 | Ullrich congenital muscular dystrophy 1 | COL6A1,COL6A2,COL6A3 |
| 260 | Usher Syndrome Type IB | MYO7A |
| 261 | Usher Syndrome Type IC | USH1C |
| 262 | Usher syndrome, type 1D | CDH23 |
| 263 | Usher Syndrome Type IF | PCDH15 |
| 264 | Usher Syndrome Type IG | USH1G |
| 265 | Usher Syndrome Type IJ | CIB2 |
| 266 | Usher Syndrome Type IIA | USH2A |
| 267 | Usher Syndrome Type IID | WHRN |
| 268 | Usher Syndrome Type IIIA | CLRN1 |
| 269 | Van Den Ende-Gupta Syndrome | SCARF2 |
| 270 | Van Maldergem Syndrome 1 | DCHS1 |
| 271 | Vici Syndrome | EPG5 |
| 272 | Factor VII Deficiency | F7 |
| 273 | Factor V deficiency | F5 |
| 274 | Warburg Micro Syndrome 1 | RAB3GAP1 |
| 275 | Warburg Micro Syndrome 2 | RAB3GAP2 |
| 276 | Warburg Micro Syndrome 3 | RAB18 |
| 277 | Wieacker-Wolff Syndrome | ZC4H2 |
| 278 | Wiskott-Aldrich Syndrome 1 | WAS |
| 279 | Multiple Epiphyseal Dysplasia with Early-Onset Diabetes Mellitus | EIF2AK3 |
| 280 | Wolfram Syndrome 1 | WFS1 |
| 281 | Wolfram Syndrome 2 | CISD2 |
| 282 | Woodhouse-Sakati syndrome | DCAF17 |
| 283 | Alport syndrome 1, X-linked | COL4A5 |
| 284 | X-linked Charcot-Marie-Tooth disease 4 | AIFM1 |
| 285 | X-linked Emery-Dreifuss Muscular Dystrophy 1 | EMD |
| 286 | X-Linked Properdin Deficiency | CFP |
| 287 | X-Linked Hypophosphatemia | PHEX |
| 288 | Macular Degeneration, X-Linked Atrophic | RPGR |
| 289 | X-Linked Myopathy with Excessive Autophagy | VMA21 |
| 290 | X-Linked Lymphoproliferative syndrome 1 | SH2D1A |
| 291 | X-Linked Lymphoproliferative syndrome 2 | XIAP |
| 292 | X-linked Chronic Granulomatous Disease | CYBB |
| 293 | X-Linked Juvenile Retinoschisis | RS1 |
| 294 | X-Linked Hypohidrotic Ectodermal Dysplasia | EDA |
| 295 | X-Linked Adrenoleukodystrophy | ABCD1 |
| 296 | Myopathy, X-linked, with postural muscle atrophy | FHL1 |
| 297 | X-linked sideroblastic anemia and ataxia | ABCB7 |
| 298 | X-linked Pigmentary disorder, reticulate, with systemic manifestations | POLA1 |
| 299 | X-linked Lissencephaly 1 | DCX |
| 300 | X-linked Lissencephaly 2 | ARX |
| 301 | X-Linked Dyskeratosis Congenita | DKC1 |
| 302 | X-Linked Adrenal Hypoplasia Congenita | NR0B1 |
| 303 | X-Linked Ocular Albinism | GPR143 |
| 304 | Spinal muscular atrophy, X-linked 2, infantile | UBA1 |
| 305 | X-linked Mental Retardation | NLGN4X |
| 306 | X-Linked Mental Retardation 12 | THOC2 |
| 307 | X-Linked Mental Retardation 1 | IQSEC2 |
| 308 | X-Linked Mental Retardation 21 | IL1RAPL1 |
| 309 | X-Linked Mental Retardation 30 | PAK3 |
| 310 | X-Linked Mental Retardation 41 | GDI1 |
| 311 | X-Linked Mental Retardation 49 | CLCN4 |
| 312 | X-Linked Mental Retardation 58 | TSPAN7 |
| 313 | X-Linked Mental Retardation 61 | RLIM |
| 314 | X-Linked Mental Retardation 72 | RAB39B |
| 315 | X-Linked Mental Retardation 90 | DLG3 |
| 316 | X-Linked Mental Retardation 93 | BRWD3 |
| 317 | X-Linked Mental Retardation 96 | SYP |
| 318 | X-Linked Mental Retardation 97 | ZNF711 |
| 319 | X-Linked Mental Retardation 98 | NEXMIF |
| 320 | X-Linked Mental Retardation 99 | USP9X |
| 321 | X-Linked Mental Retardation 9 | FTSJ1 |
| 322 | X-Linked Mental Retardation with Cerebellar Hypoplasia and Distinctive Facial Appearance | OPHN1 |
| 323 | X-Linked Mental Retardation-Hypotonic Facies Syndrome 1 | ATRX |
| 324 | X-Linked Centronuclear Myopathy | MTM1 |
| 325 | X-Linked Severe Combined Immunodeficiency | IL2RG |
| 326 | X-Linked Syndromic Mental Retardation 14 | UPF3B |
| 327 | X-Linked Syndromic Mental Retardation 15 | CUL4B |
| 328 | X-Linked Syndromic Mental Retardation 35 | RPL10 |
| 329 | X-Linked Syndromic Mental Retardation 5 | AP1S2 |
| 330 | You-Hoover-Fong syndrome | TELO2 |
| 331 | Yunis-Varon Syndrome | FIG4 |
| 332 | Alpha1-Antitrypsin Deficiency | SERPINA1 |
| 333 | Alpha-N-acetylgalactosaminidase deficiency | NAGA |
| 334 | Alpha-thalassemia | HBA1, HBA2 |
| 335 | Alpha-Mannosidosis | MAN2B1 |
| 336 | Beta-thalassemia | HBB |
| 337 | Beta-Mannosidosis | MANBA |
| 338 | Beta-Ureidopropionase Deficiency | UPB1 |
| 339 | Beta-Ketothiolase Deficiency | ACAT1 |
| 340 | Carbamoylphosphate Synthetase I Deficiency | CPS1 |
| 341 | Prolidase deficiency | PEPD |
| 342 | Interleukin 1 Receptor Antagonist Deficiency | IL1RN |
| 343 | Cataracts, Growth Hormone Deficiency, Sensory Neuropathy,sensorineural hearing loss, and skeletal dysplasia | IARS2 |
| 344 | Cataract 18 | FYCO1 |
| 345 | Cataract 40 | NHS |
| 346 | Leukocyte Adhesion Deficiency type 1 | ITGB2 |
| 347 | Leukocyte Adhesion Deficiency type 3 | FERMT3 |
| 348 | Galactokinase Deficiency | GALK1 |
| 349 | Galactosialidosis | CTSA |
| 350 | Galactosemia | GALT |
| 351 | Sudden Infant Death With Dysgenesis Of The Testes Syndrome | TSPYL1 |
| 352 | Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 1, With Or Without Fractures | B3GALT6 |
| 353 | Bowen-Conradi Syndrome | EMG1 |
| 354 | Phenylketonuria | PAH |
| 355 | Bifid Nose With Or Without Anorectal And Renal Anomalies | FREM1 |
| 356 | Pyridoxine-Refractory Sideroblastic Anemia 2 | SLC25A38 |
| 357 | Pyridoxine-Dependent Epilepsy | ALDH7A1 |
| 358 | Epidermolytic hyperkeratosis | KRT10 |
| 359 | Malonyl-Coa Decarboxylase Deficiency | MLYCD |
| 360 | Propionicacidemia | PCCA, PCCB |
| 361 | Pyruvate kinase deficiency | PKLR |
| 362 | Pyruvate Carboxylase Deficiency | PC |
| 363 | Pyruvate dehydrogenase E1-alpha deficiency | PDHA1 |
| 364 | Pyruvate Dehydrogenase E1-Beta Deficiency | PDHB |
| 365 | Pyruvate Dehydrogenase Phosphatase Deficiency | PDP1 |
| 366 | Pyruvate Dehydrogenase Lipoic Acid Synthetase Deficiency | LIAS |
| 367 | C1q deficiency | C1QA,C1QB,C1QC |
| 368 | Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy | CD55 |
| 369 | Complement Factor I Deficiency | CFI |
| 370 | Epimerase Deficiency Galactosemia | GALE |
| 371 | Hypomagnesemia 1, intestinal | TRPM6 |
| 372 | Common Variable Immune Deficiency 1 | ICOS |
| 373 | Common Variable Immune Deficiency 2 | TNFRSF13B |
| 374 | Common Variable Immune Deficiency 6 | CD81 |
| 375 | Common Variable Immune Deficiency 8 with Autoimmunity | LRBA |
| 376 | Autosomal Spastic paraplegia 30 | KIF1A |
| 377 | Autosomal Dyskeratosis Congenita 5/4 | RTEL1 |
| 378 | Alport syndrome 2, autosomal recessive | COL4A3, COL4A4 |
| 379 | Autosomal Recessive Robinow Syndrome | ROR2 |
| 380 | Autosomal Recessive T Cell-Negative、B Cell-Positive、NK Cell-Negative Severe Combined Immunodeficiency | JAK3 |
| 381 | Autosomal Recessive Persistent Hyperplastic Primary Vitreous | ATOH7 |
| 382 | Autosomal Recessive Epidermolysis Bullosa Simplex 1 | KRT14,KRT5 |
| 383 | Autosomal recessive Thrombophilia due to protein C deficiency | PROC |
| 384 | Autosomal recessive Thrombophilia due to protein S deficiency | PROS1 |
| 385 | Autosomal Recessive Deafness 1A | GJB2 |
| 386 | Autosomal Recessive Deafness 3 | MYO15A |
| 387 | Autosomal Recessive Deafness 4, with Enlarged Vestibular Aqueduct | SLC26A4 |
| 388 | Autosomal Recessive Deafness 7 | TMC1 |
| 389 | Autosomal Recessive Deafness 8/10 | TMPRSS3 |
| 390 | Autosomal Recessive Deafness 9 | OTOF |
| 391 | Autosomal Recessive Osteopetrosis 1 | TCIRG1 |
| 392 | Autosomal Recessive Osteopetrosis 2 | TNFSF11 |
| 393 | Autosomal Recessive Osteopetrosis 3 | CA2 |
| 394 | Autosomal Recessive Osteopetrosis 4 | CLCN7 |
| 395 | Autosomal Recessive Osteopetrosis 5 | OSTM1 |
| 396 | Autosomal Recessive Osteopetrosis 7 | TNFRSF11A |
| 397 | Autosomal Recessive Spinocerebellar Ataxia 10 | ANO10 |
| 398 | Autosomal Recessive Spinocerebellar Ataxia 13 | GRM1 |
| 399 | Autosomal Recessive Spinocerebellar Ataxia 16 | STUB1 |
| 400 | Autosomal Recessive Spinocerebellar Ataxia 1 | SETX |
| 401 | Autosomal Recessive Spinocerebellar ataxia 20 | SNX14 |
| 402 | Autosomal Recessive Spinocerebellar ataxia 21 | SCYL1 |
| 403 | Autosomal Recessive Spinocerebellar Ataxia 2 | PMPCA |
| 404 | Autosomal Recessive Spastic Paraplegia type 11 | SPG11 |
| 405 | Autosomal Recessive Spastic paraplegia 15 | ZFYVE26 |
| 406 | Autosomal Recessive Spastic paraplegia 23 | DSTYK |
| 407 | Autosomal Recessive Spastic paraplegia 26 | B4GALNT1 |
| 408 | Autosomal Recessive Spastic paraplegia 35 | FA2H |
| 409 | Autosomal Recessive Spastic paraplegia 45 | NT5C2 |
| 410 | Autosomal Recessive Spastic paraplegia 46 | GBA2 |
| 411 | Autosomal Recessive Spastic paraplegia 47 | AP4B1 |
| 412 | Autosomal Recessive Spastic paraplegia 50 | AP4M1 |
| 413 | Autosomal Recessive Spastic paraplegia 52 | AP4S1 |
| 414 | Autosomal Recessive Spastic paraplegia 53 | VPS37A |
| 415 | Autosomal Recessive Spastic paraplegia 54 | DDHD2 |
| 416 | Autosomal Recessive Spastic paraplegia 56 | CYP2U1 |
| 417 | Autosomal Recessive Spastic Paraplegia 9B | ALDH18A1 |
| 418 | Autosomal Recessive Cutis Laxa type 1A | FBLN5 |
| 419 | Autosomal Recessive Cutis Laxa type 1B | EFEMP2 |
| 420 | Autosomal Recessive Cutis Laxa type 1C | LTBP4 |
| 421 | Autosomal Recessive Cutis Laxa type 2A | ATP6V0A2 |
| 422 | Autosomal Recessive Cutis Laxa type 2B | PYCR1 |
| 423 | Autosomal Recessive Cytochrome B-Positive Chronic Granulomatous Disease Type I | NCF1 |
| 424 | Autosomal Recessive Cytochrome B-Positive Chronic Granulomatous Disease Type II | NCF2 |
| 425 | Autosomal Recessive Cytochrome B-Negative Chronic Granulomatous Disease | CYBA |
| 426 | Autosomal Recessive Myotonia Congenita | CLCN1 |
| 427 | Autosomal Recessive Dyskeratosis Congenita 3 | WRAP53 |
| 428 | Autosomal Recessive Microcephaly And Chorioretinopathy 1 | TUBGCP6 |
| 429 | Autosomal Recessive Microcephaly And Chorioretinopathy 3 | TUBGCP4 |
| 430 | Autosomal Recessive Spastic Ataxia 8 with Hypomyelinating Leukodystrophy | NKX6-2 |
| 431 | Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay | SACS |
| 432 | Autosomal Recessive Congenital Ichthyosis 1 | TGM1 |
| 433 | Autosomal Recessive Congenital Ichthyosis 4A | ABCA12 |
| 434 | Autosomal Recessive Congenital Ichthyosis 4B | ABCA12 |
| 435 | Autosomal Recessive Congenital Ichthyosis 5 | CYP4F22 |
| 436 | Autosomal Recessive Congenital Ichthyosis 6 | NIPAL4 |
| 437 | Autosomal Recessive Congenital Ichthyosis 9 | CERS3 |
| 438 | Autosomal Recessive Epidermolysis Bullosa Dystrophica | COL7A1 |
| 439 | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive, 1 | HPGD |
| 440 | Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy | MED23 |
| 441 | Intellectual developmental disorder, autosomal recessive 27 | LINS1 |
| 442 | Intellectual developmental disorder, autosomal recessive 38 | HERC2 |
| 443 | Intellectual developmental disorder, autosomal recessive 57 | MBOAT7 |
| 444 | Autosomal Recessive Mental Retardation 13 | TRAPPC9 |
| 445 | Autosomal Recessive Mental Retardation 15 | MAN1B1 |
| 446 | Autosomal Recessive Mental Retardation 36 | ADAT3 |
| 447 | Autosomal Recessive Mental Retardation 39 | TTI2 |
| 448 | Autosomal Recessive Mental Retardation 3 | CC2D1A |
| 449 | Autosomal Recessive Mental Retardation 41 | KPTN |
| 450 | Autosomal Recessive Mental Retardation 42 | PGAP1 |
| 451 | Autosomal Recessive Mental Retardation 44 | METTL23 |
| 452 | Autosomal Recessive Mental Retardation 49 | GPT2 |
| 453 | Autosomal Recessive Mental Retardation 58 | ELP2 |
| 454 | Autosomal Recessive Mental Retardation 5 | NSUN2 |
| 455 | Autosomal Recessive Mental Retardation 7 | TUSC3 |
| 456 | Severe combined immunodeficiency, B cell-negative | RAG1, RAG2 |
| 457 | Osteogenesis Imperfecta type XV | WNT1 |
| 458 | Osteogenesis Imperfecta type VI | SERPINF1 |
| 459 | Osteogenesis Imperfecta type VIII | P3H1 |
| 460 | Osteogenesis imperfecta, type X | SERPINH1 |
| 461 | Achalasia-Addisonianism-Alacrima Syndrome | AAAS |
| 462 | Postnatal Progressive Microcephaly With Seizures And Brain Atrophy | MED17 |
| 463 | Hemorrhagic Destruction of the Brain, Subependymal Calcification and Cataracts | JAM3 |
| 464 | Adrenocorticotropic hormone Deficiency | TBX19 |
| 465 | Neurodegeneration due to Cerebral Folate Transport Deficiency | FOLR1 |
| 466 | Epidermolysis Bullosa with Pyloric Atresia | ITGB4,ITGA6 |
| 467 | Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis(MACS syndrome) | RIN2 |
| 468 | Band-Like Calcification with Simplified Gyration and Polymicrogyria | OCLN |
| 469 | Band heterotopia | EML1 |
| 470 | Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects | B3GAT3 |
| 471 | Leukodystrophy, hypomyelinating, 2 | GJC2 |
| 472 | HSD10 mitochondrial disease | HSD17B10 |
| 473 | D-bifunctional protein deficiency | HSD17B4 |
| 474 | Autosomal Recessive Distal Spinal Muscular Atrophy 1 | IGHMBP2 |
| 475 | Donohue Syndrome | INSR |
| 476 | Gillespie syndrome, Autosomal recessive | ITPR1 |
| 477 | PERCHING syndrome | KLHL7 |
| 478 | Familial Lecithin cholesterol acyltransferase deficiency | LCAT |
| 479 | Lysosomal acid lipase deficiency | LIPA |
| 480 | Congenital Hydrocephalus 2 with or without brain or eye anomalies | MPDZ |
| 481 | Hypertrophic Neuropathy of Dejerine Sottas | MPZ |
| 482 | Cleft lip/palate-ectodermal dysplasia syndrome | NECTIN1 |
| 483 | myoclonic epilepsy of Lafora | NHLRC1 |
| 484 | Insensitivity to pain, congenital, with anhidrosis | NTRK1 |
| 485 | Coloboma, Congenital Heart Disease, Ichthyosiform Dermatosis, Mental Retardation, and Ear Anomalies Syndrome | PIGL |
| 486 | Plasminogen deficiency, type I | PLG |
| 487 | Microcephaly, seizures, and developmental delay | PNKP |
| 488 | OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR | POMC |
| 489 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | SLC19A3 |
| 490 | Autosomal Recessive Spastic paraplegia 20 | SPART |
| 491 | Salt and pepper developmental regression syndrome, Autosomal recessive | ST3GAL5 |
| 492 | Gastrointestinal defects and immunodeficiency syndrome | TTC7A |
| 493 | Kaufman oculocerebrofacial syndrome | UBE3B |
| 494 | Epidermolysis bullosa simplex with pyloric atresia | PLEC |
| 495 | Isolated Microphthalmia 8 | ALDH1A3 |
| 496 | Monocarboxylate Transporter 1 Deficiency | SLC16A1 |
| 497 | Proteasome-Associated Autoinflammatory Syndrome 1 | PSMB8 |
| 498 | Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1) | ANOS1 |
| 499 | Hypomyelinating Leukodystrophy 10 | PYCR2 |
| 500 | Hypomyelinating Leukodystrophy 12 | VPS11 |
| 501 | Hypomyelinating Leukodystrophy 14 | UFM1 |
| 502 | Hypomyelinating Leukodystrophy 3 | AIMP1 |
| 503 | Hypomyelinating Leukodystrophy 4 | HSPD1 |
| 504 | Hypomyelinating Leukodystrophy 5 | HYCC1 |
| 505 | Hypomyelinating Leukodystrophy 7 with or without oligodontia and/or hypogonadotropic hypogonadism | POLR3A |
| 506 | Hypomyelinating Leukodystrophy 8 | POLR3B |
| 507 | Epilepsy, Hearing Loss, And Mental Retardation Syndrome | AFG2A |
| 508 | Epilepsy with Variable Learning Disabilities and Behavior Disorders | SYN1 |
| 509 | Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, and Electrolyte Imbalance Syndrome | KCNJ10 |
| 510 | Arterial tortuosity syndrome | SLC2A10 |
| 511 | Short-Rib Thoracic Dysplasia 14 With Polydactyly | KIAA0586 |
| 512 | Short-rib throacic dysplasia 15 with polydactyly | DYNC2LI1 |
| 513 | Short-rib thoracic dysplasia 10 with or without polydactyly | IFT172 |
| 514 | Short-rib thoracic dysplasia 11 with or without polydactyly | DYNC2I2 |
| 515 | Short-rib thoracic dysplasia 13 with or without polydactyly | CEP120 |
| 516 | Short-rib thoracic dysplasia 2 with or without polydactyly | IFT80 |
| 517 | Short-rib thoracic dysplasia 3 with or without polydactyly | DYNC2H1 |
| 518 | Short-rib thoracic dysplasia 4 with or without polydactyly | TTC21B |
| 519 | Short-rib thoracic dysplasia 6 with or without polydactyly | NEK1 |
| 520 | Short-rib thoracic dysplasia 7 with or without polydactyly | WDR35 |
| 521 | Short-rib thoracic dysplasia 8 with or without polydactyly | DYNC2I1 |
| 522 | Short-rib thoracic dysplasia 9 with or without polydactyly | IFT140 |
| 523 | Short Stature, Microcephaly, And Endocrine Dysfunction | XRCC4 |
| 524 | Multicentric Osteolysis, Nodulosis, and Arthropathy | MMP2 |
| 525 | Multiple Sulfatase Deficiency | SUMF1 |
| 526 | Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 1 | PIGN |
| 527 | Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 3 | PIGT |
| 528 | Multiple Pterygium Syndrome,lethal type | CHRNA1 |
| 529 | Polycystic Kidney Disease 4 with or without Polycystic Liver Disease | PKHD1 |
| 530 | Multiminicore disease | RYR1 |
| 531 | Multisystem Autoimmune Disease With Facial Dysmorphism | ITCH |
| 532 | Multiple mitochondrial dysfunctions syndrome 1 | NFU1 |
| 533 | Multiple mitochondrial dysfunctions syndrome 2 | BOLA3 |
| 534 | Multiple mitochondrial dysfunctions syndrome 3 | IBA57 |
| 535 | Multiple mitochondrial dysfunctions syndrome 4 | ISCA2 |
| 536 | Polymicrogyria with Seizures | RTTN |
| 537 | Catecholaminergic Polymorphic Ventricular Tachycardia 2 | CASQ2 |
| 538 | Catecholaminergic Polymorphic Ventricular Tachycardia 5, with or without muscle weakness | TRDN |
| 539 | Childhood-Onset Polyarteritis Nodosa | ADA2 |
| 540 | Hypophosphatasia, childhood | ALPL |
| 541 | Childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy | SQSTM1 |
| 542 | Developmental Delay With Short Stature, Dysmorphic Features, And Sparse Hair | DPH1 |
| 543 | GAPO Syndrome | ANTXR1 |
| 544 | Leigh Syndrome, French-Canadian Type | LRPPRC |
| 545 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | TANGO2 |
| 546 | Fanconi anemia, complementation group A | FANCA |
| 547 | Fanconi anemia, complementation group B | FANCB |
| 548 | Fanconi anemia, complementation group C | FANCC |
| 549 | Fanconi anemia, complementation group D2 | FANCD2 |
| 550 | Fanconi anemia, complementation group E | FANCE |
| 551 | Fanconi anemia, complementation group F | FANCF |
| 552 | Fanconi anemia, complementation group G | FANCG |
| 553 | Fanconi anemia, complementation group I | FANCI |
| 554 | Fanconi anemia, complementation group L | FANCL |
| 555 | Fanconi anemia, complementation group Q | ERCC4 |
| 556 | Fanconi anemia, complementation group T | UBE2T |
| 557 | Non-Herlitz type Junctional Epidermolysis Bullosa | COL17A1 |
| 558 | Nonphotosensitive Trichothiodystrophy 4 | MPLKIP |
| 559 | Pulmonary Surfactant Metabolism Dysfunction 1 | SFTPB |
| 560 | Pulmonary Surfactant Metabolism Dysfunction 3 | ABCA3 |
| 561 | Pulmonary Venoocclusive Disease 2 | EIF2AK4 |
| 562 | Maple Syrup Urine Disease Type 1A | BCKDHA |
| 563 | Maple Syrup Urine Disease Type 1B | BCKDHB |
| 564 | Maple Syrup Urine Disease, type 2 | DBT |
| 565 | Maple Syrup Urine Disease Type 3 | DLD |
| 566 | Combined Oxidative Phosphorylation Deficiency 10 | MTO1 |
| 567 | Combined Oxidative Phosphorylation Deficiency 11 | RMND1 |
| 568 | Combined Oxidative Phosphorylation Deficiency 12 | EARS2 |
| 569 | Combined Oxidative Phosphorylation Deficiency 14 | FARS2 |
| 570 | Combined Oxidative Phosphorylation Deficiency 15 | MTFMT |
| 571 | Combined Oxidative Phosphorylation Deficiency 17 | ELAC2 |
| 572 | Combined Oxidative Phosphorylation Deficiency 1 | GFM1 |
| 573 | Combined Oxidative Phosphorylation Deficiency 20 | VARS2 |
| 574 | Combined Oxidative Phosphorylation Deficiency 23 | GTPBP3 |
| 575 | Combined Oxidative Phosphorylation Deficiency 24 | NARS2 |
| 576 | Combined Oxidative Phosphorylation Deficiency 27 | CARS2 |
| 577 | Combined Oxidative Phosphorylation Deficiency 35 | TRIT1 |
| 578 | Combined Oxidative Phosphorylation Deficiency 3 | TSFM |
| 579 | Combined Oxidative Phosphorylation Deficiency 4 | TUFM |
| 580 | Combined Oxidative Phosphorylation Deficiency 7 | MTRFR |
| 581 | Combined Oxidative Phosphorylation Deficiency 8 | AARS2 |
| 582 | Diarrhea 5 With Congenital Tufting Enteropathy | EPCAM |
| 583 | Diarrhea 7 | DGAT1 |
| 584 | Diarrhea with Microvillus Atrophy 2 | MYO5B |
| 585 | Glycine encephalopathy | AMT, GLDC |
| 586 | Glycerol Kinase Deficiency | GK |
| 587 | Nemaline Myopathy 10 | LMOD3 |
| 588 | Nemaline Myopathy 1 | TPM3 |
| 589 | Nemaline Myopathy 2 | NEB |
| 590 | Nemaline Myopathy 5 | TNNT1 |
| 591 | Nemaline Myopathy 7 | CFL2 |
| 592 | Nemaline Myopathy 8 | KLHL40 |
| 593 | Nemaline Myopathy 9 | KLHL41 |
| 594 | Wilson Disease | ATP7B |
| 595 | Hepatic Veno-Occlusive Disease with Immunodeficiency | SP110 |
| 596 | Hyper IgE Syndrome | DOCK8 |
| 597 | Homocystinuria-Megaloblastic Anemia cblG type | MTR |
| 598 | Hyperphosphatasia with Mental Retardation Syndrome 1 | PIGV |
| 599 | Hyperphosphatasia with Mental Retardation Syndrome 2 | PIGO |
| 600 | Hyperphosphatasia with Mental Retardation Syndrome 3 | PGAP2 |
| 601 | Hyperphosphatasia with Mental Retardation Syndrome 4 | PGAP3 |
| 602 | Hypermanganesemia With Dystonia 1 | SLC30A10 |
| 603 | Hypermanganesemia with dystonia 2 | SLC39A14 |
| 604 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome | SLC25A15 |
| 605 | Hyperuricemia, Pulmonary Hypertension, Renal Failure, And Alkalosis syndrome | SARS2 |
| 606 | Hyperprolinemia type I | PRODH |
| 607 | Methemoglobinemia Due to Deficiency of Methemoglobin Reductase | CYB5R3 |
| 608 | Ataxia with oculomotor apraxia type 1 | APTX |
| 609 | Ataxia with vitamin E deficiency | TTPA |
| 610 | Ataxia-Telangiectasia-Like Disorder 1 | MRE11 |
| 611 | Ataxia-telangiectasia | ATM |
| 612 | Microphthalmia, isolated 3 | RAX |
| 613 | Glutamate Formiminotransferase Deficiency | FTCD |
| 614 | Sitosterolemia | ABCG5, ABCG8 |
| 615 | Glutathione synthetase deficiency | GSS |
| 616 | Bone marrow failure syndrome 2 | ERCC6L2 |
| 617 | Bone marrow failure syndrome 3 | DNAJC21 |
| 618 | Sclerosteosis 1 | SOST |
| 619 | Osteoporosis-pseudoglioma syndrome | LRP5 |
| 620 | Citrullinemia | ASS1 |
| 621 | Cerebral creatine deficiency syndrome 2 | GAMT |
| 622 | Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome 1 | VPS33B |
| 623 | Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome 2 | VIPAS39 |
| 624 | Arthrogryposis, Mental Retardation and Seizures | SLC35A3 |
| 625 | Photosensitive Trichothiodystrophy 3 | GTF2H5 |
| 626 | Homocystinuria Due to Cystathionine Beta-Synthase Deficiency | CBS |
| 627 | Fructose 1,6 Bisphosphatase Deficiency | FBP1 |
| 628 | Peroxisome biogenesis disorder 10A | PEX3 |
| 629 | Peroxisome biogenesis disorder 11A | PEX13 |
| 630 | Peroxisome Biogenesis Disorder 14B | PEX11B |
| 631 | Peroxisome biogenesis disorder 1A(Zellweger) | PEX1 |
| 632 | Peroxisome biogenesis disorder 2A | PEX5 |
| 633 | Peroxisome biogenesis disorder 3A(Zellweger) | PEX12 |
| 634 | Peroxisome biogenesis disorder 4A | PEX6 |
| 635 | Peroxisome biogenesis disorder 5A | PEX2 |
| 636 | Peroxisome biogenesis disorder 6A(Zellweger) | PEX10 |
| 637 | Peroxisome biogenesis disorder 7A | PEX26 |
| 638 | Peroxisome biogenesis disorder 8A(Zellweger) | PEX16 |
| 639 | Peroxisomal Acyl-CoA oxidase deficiency | ACOX1 |
| 640 | Treacher Collins Syndrome 3 | POLR1C |
| 641 | Ataxia, posterior column, with retinitis pigmentosa | FLVCR1 |
| 642 | Succinic Semialdehyde Dehydrogenase Deficiency | ALDH5A1 |
| 643 | Warsaw Breakage Syndrome | DDX11 |
| 644 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | FLAD1 |
| 645 | Myopathy, lactic acidosis, and sideroblastic anemia 1 | PUS1 |
| 646 | Myopathy, Lactic acidosis, and Sideroblastic anemia 2 | YARS2 |
| 647 | Myopathy With Extrapyramidal Signs | MICU1 |
| 648 | Mulibrey nanism | TRIM37 |
| 649 | Ehlers-Danlos Syndrome, Musculocontractural type 1 | CHST14 |
| 650 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | CRPPA |
| 651 | Myofibrillar Myopathy 7 | KY |
| 652 | Myofibrillar Myopathy 8 | PYROXD1 |
| 653 | Acyl-CoA Dehydrogenase Deficiency,Very Long-Chain | ACADVL |
| 654 | Acute Recurrent Myoglobinuria | LPIN1 |
| 655 | Spinal Muscular Atrophy | SMN1 |
| 656 | Spondylo-Megaepiphyseal-Metaphyseal Dysplasia | NKX3-2 |
| 657 | Spondylocarpotarsal Synostosis Syndrome | FLNB |
| 658 | Spondyloocular syndrome | XYLT2 |
| 659 | Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy | PCYT1A |
| 660 | Spondylocostal dysostosis 1 | DLL3 |
| 661 | Spondylocostal dysostosis 2 | MESP2 |
| 662 | Spondylocostal dysostosis 4 | HES7 |
| 663 | Familial Mediterranean Fever | MEFV |
| 664 | Familial Cirrhosis | KRT8 |
| 665 | Hypercholesterolemia, familial,1 | LDLR |
| 666 | Familial Hyperinsulinemic Hypoglycemia 1 | ABCC8 |
| 667 | Familial Hyperinsulinemic Hypoglycemia 2 | KCNJ11 |
| 668 | Familial Hyperinsulinemic Hypoglycemia 4 | HADH |
| 669 | Familial Chloride Diarrhea | SLC26A3 |
| 670 | Familial Candidiasis 2 | CARD9 |
| 671 | Hemophagocytic lymphohistiocytosis, familial, 2 | PRF1 |
| 672 | Hemophagocytic lymphohistiocytosis, familial, 3 | UNC13D |
| 673 | Hemophagocytic lymphohistiocytosis, familial, 4 | STX11 |
| 674 | Hemophagocytic lymphohistiocytosis, familial, 5 | STXBP2 |
| 675 | Familial Normophosphatemic Tumoral Calcinosis | SAMD9 |
| 676 | MCEE-Related Methylmalonic Acidemia | MCEE |
| 677 | Methylmalonic aciduria and homocystinuria CblF type | LMBRD1 |
| 678 | Methylmalonic aciduria and homocysteinemia, cblX type | HCFC1 |
| 679 | MMAA-Related Methylmalonic Acidemia | MMAA |
| 680 | MMAB-Related Methylmalonic Acidemia | MMAB |
| 681 | MUT-Related Methylmalonic Acidemia | MMUT |
| 682 | Methylmalonic Aciduria and Homocystinuria cblC type | MMACHC |
| 683 | Methylmalonic Aciduria and Homocystinuria cblD type | MMADHC |
| 684 | Mevalonic Aciduria | MVK |
| 685 | Thyroid dyshormonogenesis 5 | DUOXA2 |
| 686 | Thyroid dyshormonogenesis 6 | DUOX2 |
| 687 | Pseudohypoaldosteronism, type I | SCNN1A,SCNN1B |
| 688 | Interstitial lung and liver disease | MARS1 |
| 689 | Omodysplasia 1 | GPC6 |
| 690 | Brittle Cornea Syndrome 1 | ZNF469 |
| 691 | Brittle Cornea Syndrome 2 | PRDM5 |
| 692 | Progressive Myoclonic Epilepsy 1A | CSTB |
| 693 | Progressive Myoclonic Epilepsy 1B | PRICKLE1 |
| 694 | Progressive Myoclonic Epilepsy 3 | KCTD7 |
| 695 | Progressive Myoclonic Epilepsy 4 | SCARB2 |
| 696 | Progressive Myoclonic Epilepsy 6 | GOSR2 |
| 697 | Progressive Familial Intrahepatic Cholestasis 1 | ATP8B1 |
| 698 | Progressive Familial Intrahepatic Cholestasis 2 | ABCB11 |
| 699 | Progressive Familial Intrahepatic Cholestasis 3 | ABCB4 |
| 700 | Progressive Familial Intrahepatic Cholestasis 4 | TJP2 |
| 701 | Duchenne Muscular Dystrophy | DMD |
| 702 | Progressive Pseudorheumatoid Dysplasia | CCN6 |
| 703 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy | NAXE |
| 704 | Proximal Renal Tubular Acidosis with Ocular Abnormalities | SLC4A4 |
| 705 | Argininosuccinic aciduria | ASL |
| 706 | Cerebral creatine deficiency syndrome 3 | GATM |
| 707 | Argininemia | ARG1 |
| 708 | Spastic Ataxia 2 | KIF1C |
| 709 | Spastic Ataxia 3 | MARS2 |
| 710 | Spastic Paraplegia And Psychomotor Retardation With Or Without Seizures | HACE1 |
| 711 | Megalencephalic Leukoencephalopathy with Subcortical Cysts 1 | MLC1 |
| 712 | Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A | HEPACAM |
| 713 | Giant Axonal Neuropathy-1 | GAN |
| 714 | Orofaciodigital syndrome XVI | TMEM107 |
| 715 | Orofaciodigital Syndrome V | DDX59 |
| 716 | Dilated Cardiomyopathy With Woolly Hair And Keratoderma | DSP |
| 717 | Lysinuric Protein Intolerance | SLC7A7 |
| 718 | Familial Dysautonomia | ELP1 |
| 719 | Geroderma Osteodysplasticum | GORAB |
| 720 | Tyrosinemia Type 1 | FAH |
| 721 | Tyrosinemia Type II | TAT |
| 722 | Tyrosinemia Type III | HPD |
| 723 | CK Syndrome | NSDHL |
| 724 | Refsum disease | PHYH |
| 725 | Ehlers-Danlos syndrome, spondylodysplastic type, 1 | B4GALT7 |
| 726 | Cold-induced Sweating Syndrome 1 | CRLF1 |
| 727 | Cold-induced Sweating Syndrome 2 | CLCF1 |
| 728 | Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia | MTHFD1 |
| 729 | Combined pituitary hormone deficiency 1 | POU1F1 |
| 730 | Combined pituitary hormone deficiency 2 | PROP1 |
| 731 | Combined pituitary hormone deficiency 3 | LHX3 |
| 732 | Sickle Cell Anemia | HBB |
| 733 | Desmosterolosis | DHCR24 |
| 734 | Split-Hand/Foot Malformation 6 | WNT10B |
| 735 | Lymphoproliferative Syndrome 1 | ITK |
| 736 | Lymphoproliferative Syndrome 2 | CD27 |
| 737 | Triosephosphate Isomerase Deficiency | TPI1 |
| 738 | Phosphoglycerate Kinase Deficiency | PGK1 |
| 739 | Phosphoserine Phosphatase Deficiency | PSPH |
| 740 | Thiamine-Responsive Megaloblastic Anemia Syndrome | SLC19A2 |
| 741 | Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type) | SLC25A19 |
| 742 | Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy type) | TPK1 |
| 743 | Sulfocysteinuria | SUOX |
| 744 | Craniolenticulosutural Dysplasia | SEC23A |
| 745 | Craniofrontonasal syndrome | EFNB1 |
| 746 | Craniosynostosis and Dental Anomalies | IL11RA |
| 747 | Cranioectodermal Dysplasia 1 | IFT122 |
| 748 | Craniofacial Dysmorphism, Skeletal Anomalies, And Mental Retardation syndrome | TMCO1 |
| 749 | Bare lymphocyte syndrome, type II, complementation group A | CIITA |
| 750 | Bare lymphocyte syndrome, type II, complementation group B | RFXANK |
| 751 | Bare lymphocyte syndrome, type II, complementation group D | RFXAP |
| 752 | Chronic Atrial And Intestinal Dysrhythmia | SGO1 |
| 753 | Trichohepatoenteric syndrome 1 | SKIC3 |
| 754 | Trichohepatoenteric Syndrome 2 | SKIC2 |
| 755 | Ichthyosis Follicularis-Atrichia-Photophobia Syndrome | MBTPS2 |
| 756 | Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy | QARS1 |
| 757 | Immunoskeletal dysplasia with neurodevelopmental abnormalities | EXTL3 |
| 758 | Immunodeficiency with Hyper-IgM, type 1 | CD40LG |
| 759 | Immunodeficiency with Hyper-IgM, type 3 | CD40 |
| 760 | Immunodeficiency-centromeric instability-facial anomalies syndrome 1 | DNMT3B |
| 761 | Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 2 | ZBTB24 |
| 762 | Immunodeficiency 10 | STIM1 |
| 763 | Immunodeficiency 11A | CARD11 |
| 764 | Immunodeficiency 12 | MALT1 |
| 765 | Immunodeficiency 15B | IKBKB |
| 766 | Immunodeficiency 19 | CD3D |
| 767 | Immunodeficiency 23 | PGM3 |
| 768 | Immunodeficiency 24 | CTPS1 |
| 769 | Immunodeficiency 27A | IFNGR1 |
| 770 | Immunodeficiency 28 | IFNGR2 |
| 771 | Immunodeficiency 31B | STAT1 |
| 772 | Immunodeficiency 35 | TYK2 |
| 773 | Immunodeficiency 40 | DOCK2 |
| 774 | Immunodeficiency 42 | RORC |
| 775 | Immunodeficiency 47 | ATP6AP1 |
| 776 | Immunodeficiency 48 | ZAP70 |
| 777 | Immunodeficiency 51 | IL17RA |
| 778 | Immunodeficiency 52 | LAT |
| 779 | Immunodeficiency 54 | MCM4 |
| 780 | Immunodeficiency 9 | ORAI1 |
| 781 | Arthrogryposis, distal, with impaired proprioception and touch | PIEZO2 |
| 782 | Dopa-responsive dystonia due to sepiapterin reductase deficiency | SPR |
| 783 | Molybdenum cofactor deficiency C | GPHN |
| 784 | Molybdenum Cofactor Deficiency A | MOCS1 |
| 785 | Molybdenum Cofactor Deficiency Complementation Group B | MOCS2 |
| 786 | Nijmegen breakage syndrome, | NBN |
| 787 | Nijmegen Breakage Syndrome-like Disorder | RAD50 |
| 788 | Cystic Leukoencephalopathy without Megalencephaly | RNASET2 |
| 789 | Cystic Fibrosis | CFTR |
| 790 | Cerebral Dysgenesis, Neuropathy, Ichthyosis, And Palmoplantar Keratoderma Syndrome | SNAP29 |
| 791 | Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation | DARS2 |
| 792 | Hypomyelination with brainstem and spinal cord involvement and leg spasticity | DARS1 |
| 793 | Cerebral Creatine Deficiency Syndrome 1 | SLC6A8 |
| 794 | Hydrolethalus Syndrome 1 | HYLS1 |
| 795 | Hydrolethalus Syndrome 2 | KIF7 |
| 796 | Cerebrotendinous xanthomatosis | CYP27A1 |
| 797 | Pontocerebellar hypoplasia type 10 | CLP1 |
| 798 | Pontocerebellar hypoplasia type 11 | TBC1D23 |
| 799 | Pontocerebellar hypoplasia type 1A | VRK1 |
| 800 | Pontocerebellar Hypoplasia type 1B | EXOSC3 |
| 801 | Pontocerebellar Hypoplasia, Type 1C | EXOSC8 |
| 802 | Pontocerebellar hypoplasia type 2A | TSEN54 |
| 803 | Pontocerebellar hypoplasia type 2B | TSEN2 |
| 804 | Pontocerebellar Hypoplasia type 2D | SEPSECS |
| 805 | Pontocerebellar Hypoplasia, Type 2E | VPS53 |
| 806 | Pontocerebellar hypoplasia type 6 | RARS2 |
| 807 | Pontocerebellar hypoplasia, type 7 | TOE1 |
| 808 | Pontocerebellar hypoplasia type 9 | AMPD2 |
| 809 | Cerebroretinal Microangiopathy With Calcifications And Cysts | CTC1 |
| 810 | Ventriculomegaly With Cystic Kidney Disease | CRB2 |
| 811 | Periventricular Nodular Heterotopia 2 | ARFGEF2 |
| 812 | Cerebrooculofacioskeletal Syndrome 2 | ERCC2 |
| 813 | Visceral Heterotaxy 1 | ZIC3 |
| 814 | Visceral Heterotaxy 7 | MMP21 |
| 815 | Mucopolysaccharidosis type VII | GUSB |
| 816 | Mucopolysaccharidosis Type IIIA | SGSH |
| 817 | Mucopolysaccharidosis Type IIIB | NAGLU |
| 818 | Mucopolysaccharidosis type IIIC | HGSNAT |
| 819 | Mucopolysaccharidosis type IIID | GNS |
| 820 | Mucopolysaccharidosis II | IDS |
| 821 | Mucopolysaccharidosis type IVA | GALNS |
| 822 | Mucopolysaccharidosis type IVB | GLB1 |
| 823 | Mucopolysaccharidosis type VI | ARSB |
| 824 | Mucopolysaccharidosis type V | IDUA |
| 825 | Ornithine Transcarbamylase Deficiency | OTC |
| 826 | Urofacial Syndrome 1 | HPSE2 |
| 827 | Urofacial Syndrome 2 | LRIG2 |
| 828 | Parkinson Disease 15 | FBXO7 |
| 829 | Parkinson Disease 19 | DNAJC6 |
| 830 | Pelizaeus-Merzbacher disease | PLP1 |
| 831 | Poikiloderma with Neutropenia | USB1 |
| 832 | Purine Nucleoside Phosphorylase Deficiency | PNP |
| 833 | Horizontal gaze palsy with progressive scoliosis 1 | ROBO3 |
| 834 | Polyglucosan Body Myopathy 1 With Or Without Immunodeficiency | RBCK1 |
| 835 | Mosaic variegated aneuploidy syndrome 1 | BUB1B |
| 836 | Rigid Spine Muscular Dystrophy 1 | SELENON |
| 837 | Juvenile Paget Disease | TNFRSF11B |
| 838 | Primary Lateral Sclerosis, Juvenile | ALS2 |
| 839 | Mild non-BH4-deficient Hyperphenylalaninemia | DNAJC12 |
| 840 | Achromatopsia 2 | CNGA3 |
| 841 | Achromatopsia 4 | GNAT2 |
| 842 | Achromatopsia 7 | ATF6 |
| 843 | Hyaline fibromatosis syndrome | ANTXR2 |
| 844 | Holocarboxylase synthetase deficiency | HLCS |
| 845 | Carnitine Palmitoyltransferase I Deficiency | CPT1A |
| 846 | Carnitine Palmitoyltransferase II Deficiency | CPT2 |
| 847 | Carnitine-Acylcarnitine Translocase Deficiency | SLC25A20 |
| 848 | Chylomicron Retention Disease | SAR1B |
| 849 | Cartilage-hair hypoplasia | RMRP |
| 850 | Achondrogenesis type 1A | TRIP11 |
| 851 | Achondrogenesis type 1B | SLC26A2 |
| 852 | Trifunctional Protein Deficiency | HADHA,HADHB |
| 853 | Trimethylaminuria | FMO3 |
| 854 | Short Stature, Optic Nerve Atrophy, And Pelger-Huet Anomaly | NBAS |
| 855 | Short Stature, Onychodysplasia, Facial Dysmorphism, And Hypotrichosis | POC1A |
| 856 | Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | PLAA |
| 857 | Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies | PRUNE1 |
| 858 | Neurodevelopmental Disorder with Spastic Quadriplegia and Brain Abnormalities with or without Seizures | WDR45B |
| 859 | Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy | PIGG |
| 860 | Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy | VARS1 |
| 861 | Neurodegeneration with brain iron accumulation 1 | PANK2 |
| 862 | Neurodegeneration with brain iron accumulation 2B | PLA2G6 |
| 863 | Neurodegeneration with brain iron accumulation 4(Mitochondrial Membrane Protein-Associated Neurodegeneration) | C19orf12 |
| 864 | Neuronal Ceroid-Lipofuscinoses 1 | PPT1 |
| 865 | Neuronal Ceroid-Lipofuscinoses 2 | TPP1 |
| 866 | Neuronal Ceroid-Lipofuscinoses 3 | CLN3 |
| 867 | Neuronal Ceroid-Lipofuscinoses 4A | CLN6 |
| 868 | Neuronal Ceroid-Lipofuscinoses 5 | CLN5 |
| 869 | Neuronal Ceroid-Lipofuscinoses 6 | CLN6 |
| 870 | Neuronal Ceroid-Lipofuscinoses 7 | MFSD8 |
| 871 | Neuronal Ceroid-Lipofuscinoses 10 | CTSD |
| 872 | Neuronal Ceroid Lipofuscinosis 8 | CLN8 |
| 873 | Nephropathic Cystinosis | CTNS |
| 874 | Nephrotic Syndrome Type 11 | NUP107 |
| 875 | Nephrotic Syndrome Type 12 | NUP93 |
| 876 | Nephrotic Syndrome Type 14 | SGPL1 |
| 877 | Nephrotic syndrome, type 1 | NPHS1 |
| 878 | Nephrotic Syndrome Type 2 | NPHS2 |
| 879 | Nephrotic Syndrome Type 3 | PLCE1 |
| 880 | Nephrotic Syndrome Type 7 | DGKE |
| 881 | Nephrotic Syndrome Type 9 | COQ8B |
| 882 | Nephronophthisis 11 | TMEM67 |
| 883 | Nephronophthisis 16 | ANKS6 |
| 884 | Nephronophthisis 19 | DCDC2 |
| 885 | Nephronophthisis 20 | MAPKBP1 |
| 886 | Nephronophthisis 2 | INVS |
| 887 | Nephronophthisis 3 | NPHP3 |
| 888 | Nephronophthisis-Like Nephropathy 1 | XPNPEP3 |
| 889 | Renal-Hepatic-Pancreatic Dysplasia 2 | NEK8 |
| 890 | Renal tubular dysgenesis | ACE,AGT,REN |
| 891 | Diabetes insipidus, nephrogenic, 2 | AQP2 |
| 892 | Hypomagnesemia 5, renal, with ocular involvement | CLDN19 |
| 893 | Biotinidase Deficiency | BTD |
| 894 | Growth retardation, impaired intellectual development, hypotonia, and hepatopathy | IARS1 |
| 895 | Growth Retardation, Developmental Delay, Facial Dysmorphism | FTO |
| 896 | Septooptic Dysplasia | HESX1 |
| 897 | Optic Atrophy 10 With Or Without Ataxia, Mental Retardation, And Seizures | RTN4IP1 |
| 898 | Retinal Arterial Macroaneurysm With Supravalvular Pulmonic Stenosis | IGFBP7 |
| 899 | Retinitis pigmentosa 14 | TULP1 |
| 900 | Retinitis pigmentosa 59 | DHDDS |
| 901 | Retinitis pigmentosa 77 | REEP6 |
| 902 | Retinitis pigmentosa with or without skeletal anomalies | CWC27 |
| 903 | Retinal dystrophy with macular staphyloma | CFAP410 |
| 904 | Cone-rod dystrophy | AIPL1 |
| 905 | Cone-Rod Dystrophy 10 | SEMA4A |
| 906 | Cone-Rod Dystrophy 3 | ABCA4 |
| 907 | Spondylometaepiphyseal Dysplasia, Short Limb-Hand type | DDR2 |
| 908 | bilateral frontoparietal polymicrogyria | ADGRG1 |
| 909 | Hyperphenylalaninemia, BH4-deficient, A | PTS |
| 910 | Limb pelvis hypoplasia aplasia syndrome | WNT7A |
| 911 | Spastic Tetraplegia, Thin Corpus Callosum, And Progressive Microcephaly | SLC1A4 |
| 912 | Leukodystrophy, hypomyelinating, 9 | RARS1 |
| 913 | Fetal akinesia deformation sequence 2 | RAPSN |
| 914 | Meconium Ileus | GUCY2C |
| 915 | Glycosylphosphatidylinositol Biosynthesis Defect 15 | GPAA1 |
| 916 | Glucocorticoid Deficiency 1 | MC2R |
| 917 | Glucocorticoid Deficiency 2 | MRAP |
| 918 | Glucocorticoid Deficiency 4 | NNT |
| 919 | Glycogen Storage Disease Type Ia | G6PC |
| 920 | Glycogen Storage Disease Type Ib | SLC37A4 |
| 921 | Glycogen Storage Disease Type Ic | SLC37A4 |
| 922 | Glycogen Storage Disease Type II | GAA |
| 923 | Glycogen Storage Disease type IV | GBE1 |
| 924 | Glycogen Storage Disease type III | AGL |
| 925 | Glycogen storage disease type IXa1/IXa2 | PHKA2 |
| 926 | Glycogen storage disease type IXb | PHKB |
| 927 | Glycogen storage disease type IXc | PHKG2 |
| 928 | Glycogen storage disease type IXd | PHKA1 |
| 929 | Glycogen Storage Disease type VII | PFKM |
| 930 | Glycogen Storage Disease type VI | PYGL |
| 931 | Glycogen Storage Disease type V | PYGM |
| 932 | Glycogen Storage Disease type XIV | PGM1 |
| 933 | Isolated growth hormone deficiency type III | BTK |
| 934 | Intellectual developmental disorder, X-linked, Turner type | HUWE1 |
| 935 | Aspartylglucosaminuria | AGA |
| 936 | Asparagine Synthetase Deficiency | ASNS |
| 937 | Sideroblastic Anemia With B-Cell Immunodeficiency, Periodic Fevers,And Developmental Delay | TRNT1 |
| 938 | Homocystinuria-megaloblastic anemia cblE type | MTRR |
| 939 | Diaphanospondylodysostosis | BMPER |
| 940 | Encephalopathy, Progressive, With Or Without Lipodystrophy | BSCL2 |
| 941 | Sialidosis | NEU1 |
| 942 | Ectodermal dysplasia, Ectrodactyly, and macular dystrophy Syndrome | CDH3 |
| 943 | Ectodermal Dysplasia 10b, Hypohidrotic/Hair/Tooth type | EDAR |
| 944 | Ectodermal dysplasia and immunodeficiency 1 | IKBKG |
| 945 | Lathosterolosis | SC5D |
| 946 | Reticular Dysgenesis | AK2 |
| 947 | Epilepsy, early-onset, vitamin B6-dependent | PLPBP |
| 948 | Vitamin D-dependent rickets Type IA | CYP27B1 |
| 949 | Vitamin K-dependent clotting factors, combined deficiency of, 2 | VKORC1 |
| 950 | Abetalipoproteinemia | MTTP |
| 951 | Alacrima, Achalasia, And Mental Retardation Syndrome | GMPPA |
| 952 | Lissencephaly 4 | NDE1 |
| 953 | Lissencephaly 5 | LAMB1 |
| 954 | Lissencephaly 6 | KATNB1 |
| 955 | Lissencephaly 8 | TMTC3 |
| 956 | Acheiropody | LMBR1 |
| 957 | Atransferrinemia | TF |
| 958 | Chorea-Acanthocytosis | VPS13A |
| 959 | Glutaric acidemia IIA | ETFA |
| 960 | Glutaric acidemia IIB | ETFB |
| 961 | Glutaric acidemia IIC | ETFDH |
| 962 | Glutaric Acidemia I | GCDH |
| 963 | Fatal Infantile Cardioencephalomyopathy due to Cytochrome c Oxidase Deficiency 1 | SCO2 |
| 964 | Fatal Infantile Cardioencephalomyopathy due to Cytochrome c Oxidase Deficiency 2 | COX15 |
| 965 | Congenital Diarrhea 8, Secretory Sodium | SLC9A3 |
| 966 | Congenital Cataracts, Hearing Loss, And Neurodegeneration | SLC33A1 |
| 967 | Congenital Bile Acid Synthesis Defect 1 | HSD3B7 |
| 968 | Congenital Bile Acid Synthesis Defect 2 | AKR1D1 |
| 969 | Congenital Bile Acid Synthesis Defect 3 | CYP7B1 |
| 970 | Congenital short bowel syndrome(CLMP) | CLMP |
| 971 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | PIGA |
| 972 | Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect | LGI4 |
| 973 | Hypothyroidism Congenital Nongoitrous 1 | TSHR |
| 974 | Hypothyroidism Congenital Nongoitrous 4 | TSHB |
| 975 | Congenital Dyserythropoietic Anemia Type II | SEC23B |
| 976 | Congenital Myasthenic Syndrome 10 | DOK7 |
| 977 | Congenital Myasthenic Syndrome 13 | DPAGT1 |
| 978 | Congenital Myasthenic Syndrome 14 | ALG2 |
| 979 | Congenital Myasthenic Syndrome 20 | SLC5A7 |
| 980 | Congenital Myasthenic Syndrome 3B, fast-channel | CHRND |
| 981 | Congenital Myasthenic Syndrome 4A, slow-channel | CHRNE |
| 982 | Congenital Myasthenic Syndrome 5 | COLQ |
| 983 | Congenital Myasthenic Syndrome 6 | CHAT |
| 984 | Congenital Myasthenic Syndrome 9 | MUSK |
| 985 | Muscular dystrophy, congenital, with cataracts and intellectual disability | INPP5K |
| 986 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 10 | RXYLT1 |
| 987 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 11 | B3GALNT2 |
| 988 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 12 | POMK |
| 989 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A1 | POMT1 |
| 990 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 2 | POMT2 |
| 991 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 3 | POMGNT1 |
| 992 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 4 | FKTN |
| 993 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 5 | FKRP |
| 994 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 6 | LARGE1 |
| 995 | Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies type A 8 | POMGNT2 |
| 996 | Congenital Stationary Night Blindness, Type 1A | NYX |
| 997 | Congenital Stationary Night Blindness, Type 1E | GPR179 |
| 998 | Congenital Stationary Night Blindness, Type 2B | CABP4 |
| 999 | Congenital Sodium Diarrhea | SPINT2 |
| 1000 | Congenital Hydrocephalus 1 | CCDC88C |
| 1001 | Congenital Prothrombin Deficiency | F2 |
| 1002 | Lipodystrophy, congenital generalized, type 4 | CAVIN1 |
| 1003 | Adrenal Insufficiency, Congenital, with 46XY Sex Reversal, Partial or Complete | CYP11A1 |
| 1004 | Congenital Disorders of Glycosylation Ia | PMM2 |
| 1005 | Congenital Disorders of Glycosylation Ib | MPI |
| 1006 | Congenital Disorders of Glycosylation Ic | ALG6 |
| 1007 | Congenital Disorders of Glycosylation Id | ALG3 |
| 1008 | Congenital Disorders of Glycosylation Ig | ALG12 |
| 1009 | Congenital Disorders of Glycosylation Ih | ALG8 |
| 1010 | Congenital Disorders of Glycosylation Ik | ALG1 |
| 1011 | Congenital Disorders of Glycosylation Il | ALG9 |
| 1012 | Congenital Disorders of Glycosylation Im | DOLK |
| 1013 | Congenital Disorders of Glycosylation In | RFT1 |
| 1014 | Congenital Disorders of Glycosylation Ip | ALG11 |
| 1015 | Congenital Disorders of Glycosylation Iq | SRD5A3 |
| 1016 | Congenital Disorders of Glycosylation Iv | NGLY1 |
| 1017 | Congenital Disorders of Glycosylation Iy | SSR4 |
| 1018 | Congenital Disorders of Glycosylation IIa | MGAT2 |
| 1019 | Congenital Disorders of Glycosylation IIe | COG7 |
| 1020 | Congenital Disorders of Glycosylation IIk | TMEM165 |
| 1021 | Congenital Disorders of Glycosylation IIl | COG6 |
| 1022 | Congenital Disorders of Glycosylation Iin | SLC39A8 |
| 1023 | Congenital Disorders of Glycosylation Iio | CCDC115 |
| 1024 | Congenital Insensitivity to Pain | SCN9A |
| 1025 | Congenital alopecia and T-Cell Immunodeficiency and nail dystrophy | FOXN1 |
| 1026 | Congenital Amegakaryocytic Thrombocytopenia | MPL |
| 1027 | Congenital Afibrinogenemia | FGA,FGB,FGG |
| 1028 | Congenital fiber-type disproportion myopathy | ACTA1 |
| 1029 | Congenital Thrombotic thrombocytopenic purpura | ADAMTS13 |
| 1030 | Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome | PRG4 |
| 1031 | Fibrochondrogenesis 1 | COL11A1 |
| 1032 | Fibrochondrogenesis 2 | COL11A2 |
| 1033 | Mitochondrial DNA depletion syndrome 11 | MGME1 |
| 1034 | Mitochondrial DNA depletion syndrome 13 | FBXL4 |
| 1035 | Mitochondrial DNA depletion syndrome 1 | TYMP |
| 1036 | Mitochondrial DNA depletion syndrome 2 | TK2 |
| 1037 | Mitochondrial DNA depletion syndrome 3 | DGUOK |
| 1038 | Mitochondrial DNA depletion syndrome 4A | POLG |
| 1039 | Mitochondrial DNA depletion syndrome 5 | SUCLA2 |
| 1040 | Mitochondrial DNA depletion syndrome 6 | MPV17 |
| 1041 | Mitochondrial DNA depletion syndrome 7 | TWNK |
| 1042 | Mitochondrial DNA depletion syndrome 8A/8B | RRM2B |
| 1043 | Mitochondrial DNA depletion syndrome 9 | SUCLG1 |
| 1044 | Mitochondrial Short-Chain Enoyl-CoA Hydratase 1 Deficiency | ECHS1 |
| 1045 | Mitochondrial complex I deficiency, nuclear type 1 | NDUFS4 |
| 1046 | Mitochondrial complex I deficiency, nuclear type 10 | NDUFAF2 |
| 1047 | Mitochondrial complex I deficiency, nuclear type 12 | NDUFA1 |
| 1048 | Mitochondrial complex I deficiency, nuclear type 14 | NDUFA11 |
| 1049 | Mitochondrial complex I deficiency, nuclear type 16 | NDUFAF5 |
| 1050 | Mitochondrial complex I deficiency, nuclear type 17 | NDUFAF6 |
| 1051 | Mitochondrial complex I deficiency, nuclear type 19 | FOXRED1 |
| 1052 | Mitochondrial complex I deficiency, nuclear type 21 | NUBPL |
| 1053 | Mitochondrial complex I deficiency, nuclear type 22 | NDUFA10 |
| 1054 | Mitochondrial complex I deficiency, nuclear type 4 | NDUFV1 |
| 1055 | Mitochondrial complex I deficiency, nuclear type 5 | NDUFS1 |
| 1056 | Mitochondrial complex I deficiency, nuclear type 6 | NDUFS2 |
| 1057 | Mitochondrial complex I deficiency, nuclear type 7 | NDUFV2 |
| 1058 | Mitochondrial complex I deficiency, nuclear type 9 | NDUFS6 |
| 1059 | Mitochondrial complex I deficiency, nuclear type 2 | NDUFS8 |
| 1060 | Mitochondrial complex I deficiency, nuclear type 3 | NDUFS7 |
| 1061 | Mitochondrial complex II deficiency, nuclear type 2 | SDHAF1 |
| 1062 | Mitochondrial complex IV deficiency, nuclear type 1 | SURF1 |
| 1063 | Mitochondrial complex IV deficiency, nuclear type 3 | COX10 |
| 1064 | Mitochondrial complex III deficiency nuclear type 2 | TTC19 |
| 1065 | Mitochondrial complex III deficiency nuclear type 4 | UQCRQ |
| 1066 | Mitochondrial complex III deficiency nuclear type 5 | UQCRC2 |
| 1067 | Mitochondrial complex III deficiency nuclear type 8 | LYRM7 |
| 1068 | Mitochondrial complex IV deficiency, nuclear type 11 | COX20 |
| 1069 | Mitochondrial complex IV deficiency, nuclear type 12 | PET100 |
| 1070 | Mitochondrial complex IV deficiency, nuclear type 17 | COA8 |
| 1071 | Mitochondrial complex I deficiency, nuclear type 20 | ACAD9 |
| 1072 | Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type 2 | TMEM70 |
| 1073 | Mitochondrial Neurodevelopmental disorder with abnormal movements and lactic acidosis with or without seizures | WARS2 |
| 1074 | Adenylosuccinase Deficiency | ADSL |
| 1075 | Adenosine Deaminase Deficiency | ADA |
| 1076 | Infantile Transient Liver Failure | TRMU |
| 1077 | Cerebellofaciodental Syndrome | BRF1 |
| 1078 | Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1 | VLDLR |
| 1079 | Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2 | WDR81 |
| 1080 | Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4 | ATP8A2 |
| 1081 | Microcephalic Osteodysplastic Primordial Dwarfism, Type I | RNU4ATAC |
| 1082 | Microcephalic Osteodysplastic Primordial Dwarfism, Type II | PCNT |
| 1083 | Microcephaly,Short Stature, And Limb Abnormalities | DONSON |
| 1084 | Microcephaly, Seizures, Spasticity, And Brain Calcifications | PCDH12 |
| 1085 | Microcephaly, Epilepsy, and Diabetes Syndrome | IER3IP1 |
| 1086 | Microcephaly, Short Stature, And Impaired Glucose Metabolism 1 | TRMT10A |
| 1087 | Microcephaly-Capillary Malformation Syndrome | STAMBP |
| 1088 | Microphthalmia with coloboma 3 | VSX2 |
| 1089 | Acrodermatitis Enteropathica, Zinc-Deficiency Type | SLC39A4 |
| 1090 | Neonatal Bartter syndrome type 4A with sensorineural deafness | BSND |
| 1091 | Citrullinemia, Type II, Neonatal-Onset | SLC25A13 |
| 1092 | Neonatal Diabetes Mellitus with Congenital Hypothyroidism | GLIS3 |
| 1093 | Neonatal Severe Hyperparathyroidism | CASR |
| 1094 | Lethal Neonatal Rigidity and Multifocal Seizure Syndrome | BRAT1 |
| 1095 | Hemochromatosis, type 2A | HJV |
| 1096 | Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease | ARPC1B |
| 1097 | Homocystinuria due to MTHFR deficiency | MTHFR |
| 1098 | Moyamoya disease 6 with or without achalasia | GUCY1A1 |
| 1099 | Fumarase Deficiency | FH |
| 1100 | Severe Congenital Neutropenia, Autosomal Recessive,3 | HAX1 |
| 1101 | Severe Congenital Neutropenia, Autosomal Recessive,4 | G6PC3 |
| 1102 | Severe Congenital Neutropenia, Autosomal Recessive,5 | VPS45 |
| 1103 | Severe Congenital Neutropenia, Autosomal Recessive,6 | JAGN1 |
| 1104 | Fucosidosis | FUCA1 |
| 1105 | Inflammatory Bowel Disease 28 | IL10RA |
| 1106 | Oculocutaneous Albinism Type 1 | TYR |
| 1107 | Oculocutaneous Albinism Type 2 | OCA2 |
| 1108 | Oculocutaneous Albinism Type 3 | TYRP1 |
| 1109 | Oculocutaneous Albinism Type 4 | SLC45A2 |
| 1110 | Oculocutaneous Albinism Type 6 | SLC24A5 |
| 1111 | Oculocutaneous Albinism Type 7 | LRMDA |
| 1112 | Anterior segement dysgenesis 2 | FOXE3 |
| 1113 | Anterior segement dysgenesis 7 | PXDN |
| 1114 | Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy | STRADA |
| 1115 | Insulin-Like Growth Factor I, Resistance to | IGF1R |
| 1116 | Hereditary Sensory and Autonomic Neuropathy type IIB | RETREG1 |
| 1117 | Hereditary Sensory and Autonomic Neuropathy type II | WNK1 |
| 1118 | Hereditary Sensory and Autonomic Neuropathy type V | NGF |
| 1119 | Hereditary Sensory and Autonomic Neuropathy type VIII | PRDM12 |
| 1120 | Hereditary Fructose Intolerance | ALDOB |
| 1121 | Hereditary Hyperekplexia 3 | SLC6A5 |
| 1122 | Hereditary 4 | ATAD1 |
| 1123 | Hemochromatosis type 2B | HAMP |
| 1124 | Hereditary Folate Malabsorption | SLC46A1 |
| 1125 | Hereditary Motor And Sensory Neuropathy type VIB | SLC25A46 |
| 1126 | Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum | SLC12A6 |
| 1127 | Ethylmalonic Encephalopathy | ETHE1 |
| 1128 | Hemophilia B | F9 |
| 1129 | Isobutyryl-CoA dehydrogenase deficiency | ACAD8 |
| 1130 | Metachromatic Leukodystrophy due to Arylsulfatase A | ARSA |
| 1131 | Isovaleric Acidemia | IVD |
| 1132 | Infantile liver failure syndrome 1 | LARS1 |
| 1133 | Striatonigral Degeneration, Infantile | NUP62 |
| 1134 | Hypophosphatasia, infantile | ALPL |
| 1135 | Generalized Arterial Calcification of Infancy 2 | ABCC6 |
| 1136 | Hypotonia, Infantile, With Psychomotor Retardation And Characteristic facies 1 | NALCN |
| 1137 | Hypotonia, Infantile, With Psychomotor Retardation And Characteristic facies 2 | UNC80 |
| 1138 | Hypotonia, Infantile, With Psychomotor Retardation And Characteristic facies 3 | TBCK |
| 1139 | Infantile Parkinsonism-Dystonia | SLC6A3 |
| 1140 | Infantile Sudden cardiac failure | PPA2 |
| 1141 | Free sialic acid storage disease, infantile form | SLC17A5 |
| 1142 | Infantile Cerebellar-Retinal Degeneration | ACO2 |
| 1143 | Right Atrial Isomerism | GDF1 |
| 1144 | Primary Autosomal Recessive Microcephaly 10 | ZNF335 |
| 1145 | Primary Autosomal Recessive Microcephaly 15 | MFSD2A |
| 1146 | Primary Autosomal Recessive Microcephaly 17 | CIT |
| 1147 | Primary Autosomal Recessive Microcephaly 1 | MCPH1 |
| 1148 | Primary Autosomal Recessive Microcephaly 20 | KIF14 |
| 1149 | Primary Autosomal Recessive Microcephaly 2, With Or Without Corticalmalformations | WDR62 |
| 1150 | Primary Autosomal Recessive Microcephaly 3 | CDK5RAP2 |
| 1151 | Primary Autosomal Recessive Microcephaly 4 | KNL1 |
| 1152 | Primary Autosomal Recessive Microcephaly 5 | ASPM |
| 1153 | Primary Autosomal Recessive Microcephaly 6 | CENPJ |
| 1154 | Primary Autosomal Recessive Microcephaly 7 | STIL |
| 1155 | Primary Coenzyme Q10 deficiency 1 | COQ2 |
| 1156 | Primary Coenzyme Q10 deficiency 4 | COQ8A |
| 1157 | Primary Coenzyme Q10 deficiency 6 | COQ6 |
| 1158 | Primary Coenzyme Q10 deficiency 7 | COQ4 |
| 1159 | Primary Hyperoxaluria Type I | AGXT |
| 1160 | Primary Open Angle Glaucoma 3A | CYP1B1 |
| 1161 | Primary Carnitine Deficiency | SLC22A5 |
| 1162 | Distal Arthrogryposis type 5D | ECEL1 |
| 1163 | Distal Renal Tubular Acidosis with Hemolytic Anemia | SLC4A1 |
| 1164 | Early-Onset Myopathy, Areflexia, Respiratory Distress, and Dysphagia | MEGF10 |
| 1165 | Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum | TBCD |
| 1166 | Early Infantile Epileptic Encephalopathy 16 | TBC1D24 |
| 1167 | Early Infantile Epileptic Encephalopathy 25 | SLC13A5 |
| 1168 | Early Infantile Epileptic Encephalopathy 28 | WWOX |
| 1169 | Early Infantile Epileptic Encephalopathy 34 | SLC12A5 |
| 1170 | Early Infantile Epileptic Encephalopathy 37 | FRRS1L |
| 1171 | Early Infantile Epileptic Encephalopathy 38 | ARV1 |
| 1172 | Early Infantile Epileptic Encephalopathy 3 | SLC25A22 |
| 1173 | Early Infantile Epileptic Encephalopathy 44 | UBA5 |
| 1174 | Early Infantile Epileptic Encephalopathy 48 | AP3B2 |
| 1175 | Early Infantile Epileptic Encephalopathy 49 | DENND5A |
| 1176 | Early Infantile Epileptic Encephalopathy 8 | ARHGEF9 |
| 1177 | Early Infantile Epileptic Encephalopathy 9 | PCDH19 |
| 1178 | Proliferative Vasculopathy And Hydranencephaly-Hydrocephaly Syndrome | FLVCR2 |
| 1179 | Mucolipidosis III Alpha&Beta | GNPTAB |
| 1180 | Mucolipidosis III Gamma | GNPTG |
| 1181 | Mucolipidosis IV | MCOLN1 |
| 1182 | Long-Chain 3-Hydroxyacyl-Coa Dehydrogenase Deficiency | HADHA |
| 1183 | Xeroderma Pigmentosum Group A | XPA |
| 1184 | Xeroderma Pigmentosum Group C | XPC |
| 1185 | Xeroderma Pigmentosum Group G | ERCC5 |
| 1186 | Cortical Malformations, Occipital | LAMC3 |
| 1187 | Branched-chain Ketoacid Dehydrogenase Kinase Deficiency | BCKDK |
| 1188 | Limb-Girdle Muscular Dystrophy type 2A | CAPN3 |
| 1189 | Limb-Girdle Muscular Dystrophy type 2B | DYSF |
| 1190 | Limb-Girdle Muscular Dystrophy type 2C | SGCG |
| 1191 | Limb-Girdle Muscular Dystrophy type 2D | SGCA |
| 1192 | Limb-Girdle Muscular Dystrophy type 2E | SGCB |
| 1193 | Limb-Girdle Muscular Dystrophy type 2F | SGCD |
| 1194 | Limb-Girdle Muscular Dystrophy type 2G | TCAP |
| 1195 | Limb-Girdle Muscular Dystrophy type 2H | TRIM32 |
| 1196 | Limb-Girdle Muscular Dystrophy type 2S | TRAPPC11 |
| 1197 | Limb-Girdle Muscular Dystrophy type 2T | GMPPB |
| 1198 | Acromesomelic dysplasia 1 | NPR2 |
| 1199 | Acromesomelic dysplasia 2A | GDF5 |
| 1200 | Acromesomelic dysplasia 3 | BMPR1B |
| 1201 | Rhizomelic Chondrodysplasia Punctata type 1 | PEX7 |
| 1202 | Rhizomelic Chondrodysplasia Punctata type 2 | GNPAT |
| 1203 | Rhizomelic chondrodysplasia punctata, type 3 | AGPS |
| 1204 | Lipoyltransferase 1 deficiency | LIPT1 |
| 1205 | Lipoid Congenital Adrenal Hyperplasia | STAR |
| 1206 | Pycnodysostosis | CTSK |
| 1207 | Lethal Arthrogryposis With Anterior Horn Cell Disease | GLE1 |
| 1208 | Popliteal Pterygium Syndrome, Lethal Type | RIPK4 |
| 1209 | Lethal congenital contracture syndrome 11 | GLDN |
| 1210 | Lethal Congenital Contracture Syndrome 2 | ERBB3 |
| 1211 | Lethal Congenital Contracture Syndrome 3 | PIP5K1C |
| 1212 | Lethal Congenital Contracture Syndrome 7 | CNTNAP1 |
| 1213 | Lethal Restrictive Dermopathy | LMNA,ZMPSTE24 |
| 1214 | Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies | OTUD6B |
| 1215 | Intellectual developmental disorder with cardiac arrhythmia | GNB5 |
| 1216 | Acyl-CoA Dehydrogenase Deficiency,Medium-Chain | ACADM |
| 1217 | Foveal Hypoplasia 2 | SLC38A8 |
| 1218 | Centronuclear Myopathy 2 | BIN1 |
| 1219 | Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation | NHEJ1 |
| 1220 | Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive | IL7R |
| 1221 | Transcobalamin II Deficiency | TCN2 |
| 1222 | Transaldolase Deficiency | TALDO1 |
| 1223 | Autoimmune Polyendocrine Syndrome Type 1 | AIRE |
| 1224 | Syndromic Microphthalmia 12 | RARB |
| 1225 | Microphthalmia, syndromic 9 | STRA6 |
| 1226 | Histiocytosis-lymphadenopathy plus syndrome | SLC29A3 |
| 1227 | Hypoplastic Left Heart Syndrome 1 | GJA1 |
| 1228 | Aromatic L-Amino Acid Decarboxylase Deficiency | DDC |
| 1229 | Orofaciodigital Syndrome XIV | C2CD3 |
| 1230 | Cone-Rod Dystrophy 16 | CFAP418 |
| 1231 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | MCCC1 |
| 1232 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | MCCC2 |
| 1233 | Gitelman syndrome | SLC12A3 |
| 1234 | Glucose-6-Phosphate Dehydrogenase Deficiency | G6PD |
| 1235 | Short Chain Acyl-CoA Dehydrogenase Deficiency | ACADS |
| 1236 | Achromatopsia 3 | CNGB3 |

1. Избери твоето изследване
Свтржи се с нас за предварителна консултация, ако имаш нужда от съвет кое е най-подходящото изследване за теб от тези, които предлагаме. Препоръката се определя на база на това дали има наличие на генетично заболяване в рода ти, неговия вид, дали имаш родствена близост с партньора си и др.

2. Взимане на ДНК материал
За изследването са необходими 5ml кръв.

3. ДНК анализ в сертифицирана лаборатория
Взетата проба ще бъде изпратена до сертифицираната лаборатория BGI. Твоят резултат ще е готов в рамките на 25-30 работни дни.

4. Анализ на резултата
Лекар, специалист по медицинска генетика, ще изготви подробен анализ на твоя резултат с цел да получиш максимално точни, актуални и приложими решения.

5. Консултация
Твоята услуга включва и консултация на живо или дистанционно с лекаря генетик, който е анализирал резултата ти.